Fulminant myocarditis induced by immune checkpoint inhibitors: a case report

14 March 2025 (08:45 - 18:30)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Miss Alexandra Sakka

251 Air Force General Hospital, Athens (Greece)

5 More presentations in this session

Presentation thumbnail

Thyrotoxicosis and liver cirrhosis induced high-output state: an uncommon cause of acute heart failure

Doctor R. Karlsson (Dublin, IE)

Presentation thumbnail

Takotsubo-like catecholamine cardiomyopathy secondary to paraganglioma.

Doctor P. Mas Ballester (Barcelona, ES)

Presentation thumbnail

An awkward dyspnea in a young and healthy boy.

Doctor M. Hernandez Hidalgo (Salamanca, ES)

Presentation thumbnail

Worsening heart failure: from guidelines to emerging evidence. a pathway where the patient must persist the main focus

Doctor T. Recchioni (Rome, IT)

Presentation thumbnail

Severe heart failure and complex arrhythmias induced by performance enhancing drugs in a young bodybuilder: unmasking the psychological link

Doctor I. Sooltan (Edinburgh, GB)

Access the full session

Session thumbnail

Challenging cases in heart failure and cardiomyopathies: rare etiologies and emerging perspectives

The Event

Event poster

ESC Acute CardioVascular Care 2025

14 March - 15 March 2025

You may be interested in

Congress Presentation

When an anticancer drug silently attacks the heart - severe but due to diabetic neuropathy oligosymptomatic immune checkpoint inhibitor-associated perimyocarditis with LV outflow tract obstruction

Congress Presentation

A case of awake VA-ECMO in a fulminant myocarditis induced by immune checkpoint inhibitor

Congress Presentation

A case of immune-related adverse events (irAEs) myocarditis with marked ST-segment elevation requiring differentiation from Covid-19-induced myocarditis.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources